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Fig 1. Freedom from stroke/death for creatinine. SE, Standard error.
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Volume 60, Number 3 Abstracts 833Methods: National Inpatient Sample (2000-2011) data were used
to evaluate patient characteristics, outcomes, and perioperative costs
for elective EVAR performed for an intact abdominal aortic aneurysm
(AAA). Outcomes were adjusted for patient demographics and comor-
bidities and for hospital factors by multivariate analysis. Costs were
calculated from hospital cost-to-charge ratio ﬁles and adjusted to 2011
dollars.
Results: From 2000 to 2011, 185,249 patients underwent elective
EVAR for an intact AAA. The absolute rates of in-hospital major morbidity,
mortality, and procedural costs all decreased signiﬁcantly over time (P <
.0001; Fig, A). The prevalence of major comorbidities in patients undergo-
ing EVAR, including obesity, diabetes, and dyslipidemia, all increased signif-
icantly over time. After adjusting for multiple demographics, comorbidities,
and hospital-level factors, recent outcomes of EVAR (2009-2011) remain
superior to the early experience (2000-2002) with respect to mortality
and major complications (Fig, B).
Conclusions: Advanced technology is often implicated in escalating
health care spending, and the “value” (deﬁned as outcomes relative to
cost) of expensive, novel techniques is often questioned. From 2000 to
2011, the outcomes of EVAR improved signiﬁcantly despite a higher prev-
alence of comorbidities among patients undergoing repair. Concurrently,
procedure-associated costs declined. These ﬁndings highlight the increasing
“value” of EVAR over time.
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Objectives: This study evaluated whether increased experience with
endovascular abdominal aortic aneurysm (AAA) repair (EVAR) for ruptured
AAA (rAAA) has improved patient outcomes.
Methods: The National Surgical Quality Improvement Program
(NSQIP) database was queried, from the years 2005 to 2011, to identify pa-
tients who underwent EVAR for rAAA. A total of 803 EVAR procedures
were performed for rAAA. Procedures performed between 2005 and
2007 were placed into the early EVAR (E-EVAR) group and those per-
formed between 2008 and 2011 were placed into the late EVAR (L-
EVAR) group. Patient demographics, comorbidities, perioperative data,
and outcomes were compared.
Results: More EVAR procedures were performed for rAAA in the L-
EVAR group than in the E-EVAR group (124 vs 679, P < .01). The groups
were similar with regards to demographics and preoperative comorbid con-
ditions. There was a lower rate of acute renal failure (9% vs 15%, P ¼ .03),
pneumonia (11% vs 18%, P ¼ .03), and deep venous thrombosis (0% vs 2%,
p4 units) (16% vs 4%, P < .01). The L-EVAR group had shorter operative
times (173 vs 187 minutes, P < .01) despite the trend toward hemodynamic
instability. Mortality on the day of surgery (10% vs 10%, P ¼ .82) and 30-
day mortality (26% vs 24%, P ¼ .69) were not signiﬁcantly different between
E-EVAR and L-EVAR.
Conclusions: There has been an increase in the use of EVAR for he-
modynamically unstable patients with rAAA, with acceptable immediate and
30-day mortality rates. The ﬁndings may be attributed to an improvement
in EVAR devices and/or the surgeons’ comfort level with the use of
EVAR for rAAA. These data suggest that EVAR is an effective treatment
for rAAA even in the setting of an unstable patient.
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A. Stone, Albeir Y. Mousa, Will Jackson. West Virginia University,
Charleston Division, Charleston, WVa>Eastern Vascular SocietyObjective: Several studies have reported mixed results after carotid
endarterectomy (CEA) in patients with chronic renal insufﬁciency (CRI);
however, only a few used the glomerular ﬁltration rate (GFR; Modiﬁcation
of Diet in Renal Disease) to analyze long-term outcome.
Methods: A total of 926 patients who had GFR and/or serum
creatinine (Cr) were classiﬁed into normal (GFR $60 mL or Cr <1.5
mg/dL, group A), moderate CRI (GFR $30-59 mL or Cr $1.5-2.9
mg/dL, group B), and severe CRI (GFR <30 mL or Cr $3 mg/dL,
group C).
Results: The stroke and death rates (early and late [mean follow-up:
35 months]) were 9%, 18%, and 44% for Cr groups A, B, and C (P ¼
.0001) in contrast to 8%, 14%, and 26% for GFR groups A, B, and C (P
¼ .0003). The stroke-free survival rates at 1, 2, and 3 years were 97%,
94%, and 92%; 92%, 85%, and 81%; and 56%, 56%, and 56% for Cr groups
A, B, and C, respectively (P < .0001, Fig 1), in contrast to 98%, 95%, and
93%; 93%, 90%, and 86%; and 86%, 77%, and 73% for GFR groups A, B, and
C (P < .0001, Fig 2). These rates for asymptomatic patients at 1, 2, and 3
years were 97%, 95%, and 93%; 94%, 87%, and 82%; and 56%, 56%, and 56%
for Cr groups A, B, and C, respectively (P < .0001), in contrast to 98%,
95%, and 94%; 95%, 91%, and 86%; and 84%, 80%, and 75% for GFR groups
A, B, and C (P ¼ .0026). A multivariate analysis showed that Cr$3 mg/dL
and GFR <30 mL had a HR of stroke and death of 4.7 and 2.2, respectively
(P ¼ .008).
Conclusions: Cr and GFR were sensitive in detecting late stroke/
death after CEA in patients with CRI. Patients with severe CRI had
higher rates of early and late stroke/death; therefore, CEA for these pa-
tients (particularly asymptomatic patients) must be considered with
caution.
